Another study indicated that a combination of Vitamin D and dipeptidyl peptidase-4 (DPP-4) inhibitors preserved β-cell function and prolonged disease remission phases in type 1 diabetes, demonstrating synergistic anti-inflammatory and immune-regulatory effects [55]. Here, DPP4 is linked to type 1 diabetes mellitus.